尊龙凯时(中国)登录入口
Other Affiliated Sites
Techdow Pharma China
Techdow Pharma UK
Techdow Pharma Poland
Techdow Pharma Italy
Techdow Pharma Spain
Techdow Pharma Germany
Techdow Pharma US
Cytovance Biologics
SPL
Simplified Chinese
Traditional Chinese
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
Global Industrial Chain
Global Heparin Preparations Business
Product Profile
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Disclosures
A-Share Information
H-Share Information
Financial Reports
Announcements
2024.04.30
尊龙凯时:2024年一季度報告
2024.03.29
尊龙凯时:2023年年度報告
2023.10.30
尊龙凯时:2023年三季度報告
2023.08.30
尊龙凯时:2023年半年度報告
2023.04.28
尊龙凯时:2023年第一季度報告
2023.03.30
2022年年度報告
2022.10.28
尊龙凯时:2022年三季度報告
2022.08.30
尊龙凯时:2022年半年度報告
2022.04.30
2022年一季度報告
2022.04.12
尊龙凯时:2021年年度報告(更新後)
第一頁
上一頁
1
2
3
4
5
下一頁
最後一頁
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Official WeChat Account
Legal Statement
·
Environmental Disclosure
Copyright © 2022 Hepalink Group. All Rights Reserved.